00:00We are. We're changing it up.
00:01Changing it up. Very good.
00:02Kicking off the 9 o'clock hour with some stocks to watch. Why not?
00:05So Accenture, ticker symbol here, ACN, that stock on the move upward today, up about 4%.
00:12Anthropik says it has partnered with Accenture, which is a technology consulting company,
00:17to test the safety of its advanced artificial intelligence models.
00:23Anthropik calling this partnership an important step toward its commitment to pace development of the technology.
00:28We know there's been so much talk about the heads of these AI companies saying that things may indeed be
00:33moving too quickly.
00:34And Accenture shares are down more than 30% so far this year over concerns about corporate IT spending,
00:41concerns that AI tools could take away business from professional service firms like its own.
00:46So this is a big deal for Accenture today.
00:49What else we got?
00:51Our house. Do you know this? This is the furniture store.
00:53Yeah, they have a few big locations, especially one down in Soho.
00:57So this ticker symbol is ARHS, stock up more than 9%.
01:03An analyst says it is likely to break back into the green as it ramps up its digital marketing
01:08and other efforts to expand its customer base.
01:10This is according to Jeffries.
01:12So the investment bank upgrading the home furnishing stock to buy from hold,
01:15raising its price target on shares to $10 from $9.50.
01:20Shares of our house are down 31% year to date, by the way.
01:25And Jeffrey's call goes against the consensus on the street right now of the 15 analysts covering
01:30our house, seven have a buy or strong buy on the stock, while eight have a hold on it.
01:35But they say that over the past few weeks, they're seeing more website traffic.
01:38It's more than doubled on a year-over-year basis.
01:40And they say they also want to expand into B2B strategy.
01:44So business to business for our house.
01:46We'll see how that goes.
01:47Our house.
01:47You know what?
01:48No.
01:48No.
01:48All right.
01:49I learned something new today.
01:51Changing it up with Tom Gunn.
01:52Exactly.
01:53All right.
01:53One more.
01:54All right.
01:54Novo Nordisk.
01:56Disappointing investors here.
01:57They were hoping for more concrete turnaround plans from the drug maker.
02:00We know that it was first to market with these GLP-1 weight loss drugs, but it quickly lost
02:05its lead to Eli Lilly.
02:07So Novo is promising to launch more than five blockbuster drugs and deliver more than $23
02:12billion in new sales in the coming year.
02:14But that wasn't enough for investors.
02:16They are selling the stock today because they are not seeing concrete news that they say
02:20will drive the stock higher.
02:22Novo has fallen behind Lilly.
Comments